Injecting drug users who are (un)aware of their HIV serostatus: findings from the multi-center study AjUDE-Brasil II

Cadernos de Saúde Pública

Aline Dayrell Ferreira²  Waleska Teixeira Caiaffa²  Francisco I. Bastos¹  Sueli Aparecida Mingoti¹ 

[1] ,Universidade Federal de Minas Gerais Faculdade de Medicina Belo Horizonte Minas Gerais ,Brasil

关键词: AIDS Serodiagnosis;    Intravenous Substance Abuse;    Acquired Immunodeficiency Syndrome;    HIV;    Sorodiagnóstico da AIDS;    Uso Indevido de Drogas Parenterais;    Síndrome de Imunodeficiência Adquirida;    HIV;   

DOI  :  10.1590/S0102-311X2006000400020

来源: SciELO

【 摘 要 】

This study aimed to characterize the profiles of injecting drug users (IDUs) who were unaware of their HIV serostatus, given the importance of this information for prevention strategies, especially in this vulnerable population, key to the HIV/AIDS dynamic. As part of a cross-sectional multi-city survey, IDUs were interviewed and HIV-tested by the ELISA technique. IDUs were categorized according to knowledge of their own HIV status as either aware or unaware. Means, averages, and proportions were compared between the groups using bi- and multivariate analyses. Of 857 IDUs interviewed, 34.2% were unaware of their HIV serostatus. Those who were unaware were more likely: to have been recruited at sites where the HIV prevalence rate was considered medium (> 10 to 50%; odds ratio = 8.0) or high (> 50%; 4.0); to be illiterate (OR = 4.54); to have no prior HIV test (OR = 2.22); to be male (OR = 1.81); and to have been enrolled more recently in syringe-exchange programs (OR = 1.69). HIV prevention programs should target both individuals at risk and HIV-positive individuals. Programs to expand access to HIV testing are pivotal and should be tailored to specific contexts and populations.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License